Drug Shortage Report for test
| Report ID | 257127 |
| Drug Identification Number | |
| Brand name | test |
| Common or Proper name | test |
| Company Name | 6646158 CANADA INC. |
| Market Status | |
| Active Ingredient(s) | test |
| Strength(s) | test |
| Dosage form(s) | test |
| Route of administration | test |
| Packaging size | |
| ATC code | test |
| ATC description | test |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2026-02-03 |
| Actual start date | |
| Estimated end date | 2028-05-06 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-06-18 |
| Company comments | test |
| Health Canada comments | test |
| Tier 3 Status | No |
| Contact Address | 2251 RUE LAPIERRE LASALLE, QUEBEC CANADA H8N 1B7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-06-18 | French | Compare |
| v1 | 2025-06-18 | English | Compare |
Showing 1 to 2 of 2